SEP 26, 2022 7:57 AM PDT

A Rheumatoid Arthritis-Promoting Molecule is Identified

WRITTEN BY: Carmen Leitch

Researchers have found that a protein called sulfatase-2 may play a significant role in the tissue damage caused by rheumatoid arthritis, an autoimmune condition in which the joints are targeted and attacked by the immune system. The findings have also provided new insights into the mechanisms underlying rheumatoid arthritis, which could help scientists develop better treatments for the millions of people who have the disorder. The work has been reported in Cellular & Molecular Immunology.

Image credit: Pixabay

While sulfatases, including sulfatase-2 have already been investigated for their roles in cancer, researchers were interested in whether they were also related to inflammatory conditions. To learn more, they used a synovial fibroblast cell model; these cells line and lubricate the joints, allowing them to move freely.

Inflammatory signals including a molecule called TNF-alpha (tumor necrosis factor-alpha) can activate these cells in rheumatoid arthritis, and they can become "aggressive," explained first study author Ruby J. Siegel, a graduate student in the WSU College of Pharmacy and Pharmaceutical Sciences. "They are not dying when they should, and they proliferate in a way that is almost tumor-like, forming this massive synovial tissue that should not be anywhere near that size and at the same time activating proteins that destroy cartilage and bone."

Many arthritis therapies that are now available target TNF-alpha, noted senior study author Salah-Uddin Ahmed, a professor in Washington State University's College of Pharmacy and Pharmaceutical Sciences. But patients can develop resistance to those drugs. "That is why we were looking for previously undiscovered drug targets in TNF-alpha signaling, so basically proteins that it interacts with that may play a role."

The investigators eliminated sulfatase-2 from a group of the cells, then exposed all of them to TNF-alpha. They determined that the cells without sulfatase-2 did not have an exaggerated inflammatory reaction to TNF-alpha while cells that expressed sulfates-2 did, however.

"Looking at sulfatases for their potential role in inflammation was an educated guess, but once we did we saw a very consistent pattern of increased sulfatase-2 expression throughout different tissues and samples we studied," Ahmed said. "This tells us that TNF-alpha relies on sulfatase-2 to drive inflammation, because as soon as we removed sulfatase-2 the inflammatory effects of TNF-alpha were markedly reduced."

Sources: Washington State University, Cellular & Molecular Immunology

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 02, 2022
Coronavirus
Omicron-Specific Booster Shots Will be Available Soon
SEP 02, 2022
Omicron-Specific Booster Shots Will be Available Soon
Soon, vaccine booster shots that are specific to the Omicron variant will be available in many countries. The new Omicro ...
SEP 18, 2022
Immunology
Surprising Roles for Hormones in Wound Repair
SEP 18, 2022
Surprising Roles for Hormones in Wound Repair
When we get a bacterial infection in our skin, our immune system responds. It's been thought that inflammatory cells ...
SEP 23, 2022
Immunology
Successful Immunotherapy Trial Sends Lupus Into Remission
SEP 23, 2022
Successful Immunotherapy Trial Sends Lupus Into Remission
Immunotherapy is generally known as a treatment for cancer. In CAR T cell therapy, a patient's T cells can be isolat ...
SEP 26, 2022
Cancer
Clinical Trial Suggests Oncolytic Virus Effective in Combination with Immune Checkpoint Inhibition
SEP 26, 2022
Clinical Trial Suggests Oncolytic Virus Effective in Combination with Immune Checkpoint Inhibition
One type of cancer immunotherapy, called oncolytic viral therapy, works by infecting cancer cells with a specific virus. ...
NOV 03, 2022
Clinical & Molecular DX
Co-Infections of COVID-19 and the Flu were Common Last Winter, Researchers Find
NOV 03, 2022
Co-Infections of COVID-19 and the Flu were Common Last Winter, Researchers Find
Infections of SARS-CoV-2, or COVID-19, do not always occur on their own. A COVID-19 infection can occur at the same time ...
NOV 18, 2022
Immunology
COVID-19 Can Reactivate Latent Viruses
NOV 18, 2022
COVID-19 Can Reactivate Latent Viruses
Viral infections can trigger other dormant, or latent viruses. For example, the herpesviruses HSV and CMV can be reactiv ...
Loading Comments...